S

Stablix, Inc.

26 employees

Stablix Therapeutics is a biotechnology company pioneering the field of Targeted Protein Stabilization (TPS).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2021

Funding rounds raised

Total raised

$63M

from 1 investors over 1 rounds

S

Stablix, Inc. raised $63M on June 3, 2021

Investors: Versant Ventures

FAQ